🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting insights into #ProstateCancer therapy! 🙌 Di Zhao MDA joins Andrea Miyahira to discuss the therapeutic vulnerability of immune checkpoint B7-H3 in #PCa with PTEN and TP53 deficiencies. Potential breakthroughs in treating adv prostate cancer > bit.ly/3DzJsrY

So proud of you, Javier! Keep rising! Javier Leo

My first Boot Walk with family! So proud to be an employee of MD Anderson Cancer Center to #EndCancer together!

Congrats ⁦Di Zhao MDA⁩! #AACR2025 #radonc #endcancer

Big congratulations to Dr. Ron DePinho for receiving the AACR-Princess Takamatsu Memorial Lectureship🎊👏 What a role model with superb achievements! 🎉🥳🏆

I am so honored to be selected as #AACR2025 NextGen Star and present MD Anderson Cancer Center to give a talk at #AACR2025 meeting!

Congratulations to our Dr. Han Liang on receiving the AACR-Award for Outstanding Achievement in Basic Cancer Research. In his award lecture at #AACR25, he shared how his research aims to fill the gap between big data and precision medicine. Learn more about the award and Dr.

In a preclinical model of prostate cancer, dual blockade of B7-H3/PD-L1 or B7-H3/CTLA-4 achieves durable anti-tumor effects, our Dr. Di Zhao presented at #AACR25 this afternoon. Di Zhao MDA AACR #EndCancer

Big Congratulations to FeiyuChen for receiving the Scholarship-in-training award 🥇🎉and giving an excellent talk 👍👏at #AACR2025 annual meeting! So proud of you! #MDAnderson

Excellent work and beautiful talk! Congratulations to Linghua Wang, MD, PhD and the team! 🎊🎉🌹👏

Another successful #AACR annual meeting! So excited that my mentor Dr. Ron DePinho, my trainee FeiyuChen, and myself, received awards and recognitions and gave talks at #AACR2025 👏 That’s how science shines and passages from generation to generation 🥳 MD Anderson Cancer Center

Thrilled to share our latest work published in #NatureCancer! 🥳We uncover the metabolic vulnerability of and develop novel therapy for advanced prostate cancer with SPOP and CHD1 defects! Grateful to my amazing team, collaborators, and supporters! 🙏MD Anderson Cancer Center Read it here:

So excited that our #NatureCancer paper was highlighted by my home institute MD Anderson Cancer Center. Tones of thanks to the unwavering support from my chair Dr. Junjie Chen and Division #RadOnc Albert Koong, MD PhD